Ani Kardashian, MD

Assistant Professor of Clinical Medicine

Image of Ani Kardashian, MD
Is this your profile? Click to edit

Overview

Dr. Ani Kardashian is an Assistant Professor of Medicine in the Division of Gastroenterology and Liver Diseases at the Keck School of Medicine at the University of Southern California. She is a transplant hepatologist who specializes in caring for patients with fatty liver, cirrhosis, and patients who undergo liver transplantation. Her research interests include understanding the social factors that contribute to the development and management of chronic liver diseases, viral hepatitis and nonalcoholic fatty liver disease, and liver disease in HIV infection.

Dr. Kardashian received her MD from the University of California, San Francisco and completed Internal Medicine residency at the University of California, San Francisco. She then completed fellowships in Gastroenterology at University of California, Los Angeles and in Transplant Hepatology from the University of California, San Francisco. Dr. Kardashian is a member of the American College of Gastroenterology, American Gastroenterological Association, and American Association for the Study of Liver Diseases. She is board certified by the American Board of Internal Medicine in internal medicine, gastroenterology, and transplant hepatology.

Awards

  • University of Southern California: Mentored Career Development in Clinical and Translational Science Program (KL2), 2022
     – 2025
  • International Liver Congress/EASL: Young Investigator Bursary Award for Outstanding Abstract, 2021
  • Department of Medicine, University of California San Francisco: Clinical Fellow of the Year, 2020
  • American Society of Transplantation: Women’s Health Community of Practice Outstanding Abstract Award, 2020
  • American Association for the Study of Liver Diseases: Advanced/Transplant Hepatology Award (grant), 2019
     – 2021
  • American College of Gastroenterology: Young Physicians Leadership Program, 2018
     – 2019
  • HIV and Liver Disease Seventh Biennial Meeting: Young Investigator Award, 2018
  • American Association for the Study of Liver Diseases: Resident/Fellow Ambassador Award, 2017
     – 2018
  • HIV and Liver Disease Sixth Biennial Meeting: Young Investigator Award, 2016
  • American Association for the Study of Liver Diseases: Emerging Liver Scholar, 2015
  • University of California San Francisco School of Medicine: Clinical and Translational Research Award, 2015
  • University of California San Francisco School of Medicine: Alpha Omega Alpha, 2013
  • Stanford University: Graduated with Distinction, 2008
  • Stanford University: Phi Beta Kappa, 2007

Education and Training

  • Stanford University — B.A. — 2008 — Human Biology
  • University of California, San Francisco — M.D. — 2013 — School of Medicine
  • University of California, San Francisco — Internship/Residency — 2016 — Department of Medicine
  • University of California, Los Angeles — Fellowship in Gastroenterology — 2019
  • University of California, San Francisco — Fellowship in Advanced/Transplant Hepatology — 2020
  • University of Southern California — M.S. — 2025 — Clinical Translational Research

Research Funding

  • Food Insecurity and Diet Quality: Effects on Liver Disease in People with HIV
    NIH · K23DK142591 · Sep 1, 2025 – Aug 31, 2029 · Role: Principal Investigator
  • NIH
    NIH · KL2TR001854 · Apr 1, 2022 – Jul 31, 2025 · Role: Principal Investigator
  • USC
    USC · Role: Principal Investigator

Publications

  • Erratum: Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV. AIDS. 2026 Jan 01; 40(1):132.. View in PubMed
  • Liver disease in women with HIV. Curr Opin HIV AIDS. 2026 Jan 01; 21(1):67-74.. View in PubMed
  • The association of food insecurity with hepatic steatosis in women with and without HIV. AIDS. 2025 Dec 01; 39(15):2209-2217.. View in PubMed
  • Gender Equity in Gastroenterology: Perspectives From the AGA Women’s Committee on Current Frameworks and Future Directions. Clin Gastroenterol Hepatol. 2025 Aug; 23(9):1467-1471.. View in PubMed
  • Gender Equity in Gastroenterology: Perspectives From the AGA Women’s Committee on Current Frameworks and Future Directions. Gastroenterology. 2025 Aug; 169(2):195-199.. View in PubMed
  • Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV. AIDS. 2025 Jul 15; 39(9):1185-1190.. View in PubMed
  • Neighborhood Social Determinants of Health Are Associated With Metabolic Dysfunction-associated Steatotic Liver Disease Outcomes. Clin Gastroenterol Hepatol. 2025 Aug; 23(9):1577-1587.e10.. View in PubMed
  • Increasing pharmacoequity for people with cirrhosis. Clin Liver Dis (Hoboken). 2024 Jan-Jun; 23(1):e0203.. View in PubMed
  • Pragmatic strategies to address health disparities along the continuum of care in chronic liver disease. Hepatol Commun. 2024 05 01; 8(5).. View in PubMed
  • Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV. Clin Gastroenterol Hepatol. 2024 Jul; 22(7):1427-1435.e6.. View in PubMed